Resource Library
Accelerating biomanufacturing facility readiness: A scalable validation model for multiproduct facilities
Facility readiness is essential for meeting project timelines — especially for multiproduct biologics manufacturing, as complexity and regulatory demands continue to evolve.
Samsung Biologics has developed a scalable validation framework leveraging its expertise acquired by building large-scale plants. Now applied to Plant 5, this strategy enables faster, compliant start-up across diverse client programs.
Facility readiness is essential for meeting project timelines — especially for multiproduct biologics manufacturing, as complexity and regulatory demands continue to evolve.
Samsung Biologics has developed a scalable validation framework leveraging its expertise acquired by building large-scale plants. Now applied to Plant 5, this strategy enables faster, compliant start-up across diverse client programs.